Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose safety, tolerability, pharmacokinetics, and formulation exploration study of W28F in healthy volunteers
ChiCTR-TNC-12002605Phase 4Completed
- Sponsor
- Shanghai Xuhui District Central Hospital
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of isothiafludine in hepatitis B (HBV) (4 arms), sponsored by Shanghai Xuhui District Central Hospital. Primary endpoint: Rate of adverse events. Started Jul 2012; status: completed.
02
Drugs
isothiafludine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ChiCTR-TNC-12002605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-12002605.